Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial metabolism in dental plaque encompasses the collective metabolic activities of the diverse microbial community within dental biofilms. This complex process involves the breakdown of dietary carbohydrates and endogenous substrates, leading to the production of acids and other metabolites that contribute to the development of dental caries and other oral diseases. The composition and activity of the plaque microbiome are influenced by factors such as diet, saliva, and interspecies interactions.
Varies depending on the specific intervention: Antimicrobials target bacterial cell structure/function; Fluoride inhibits demineralization and promotes remineralization; Xylitol is non-fermentable and disrupts bacterial metabolism; Probiotics introduce beneficial bacteria; Prebiotics promote the growth of beneficial bacteria.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Metabolism in Dental Plaque.